查詢結果分析
相關文獻
- Diagnostic Role of Endoscopy, Stool Culture, and Toxin a in Clostridium Difficile-Associated Disease
- A Toxin Conjugate Containing Transforming Growth Factor-α and Ricin a Specifically Inhibits Growth of A431 Human Epidermoid Cancer Cells
- 細菌之核苷核糖化毒素:綠膿桿菌外毒素A
- 痙攣治療新趨勢--臘腸菌毒素A注射
- 赭麴毒素A及T-2毒素單獨及混合後對肉雞所產生的影響
- 重組第一類轉形生長因子與篦麻毒素A融合蛋白質對人類癌症細胞之生長抑制效應
- 肉毒桿菌毒素A在眼科學的應用
- 動物用T細胞疫苗(T cell vaccine)之研究
- 醫療上的利器--改造的綠膿桿菌外毒素A
- 臘腸菌毒素A在斜視治療之應用
頁籤選單縮合
題 名 | Diagnostic Role of Endoscopy, Stool Culture, and Toxin a in Clostridium Difficile-Associated Disease=內視鏡,糞便培養及毒素A在Clostridium Difficile相關疾病的診斷角色 |
---|---|
作 者 | 魏淑珍; 翁昭旼; 薛博仁; 謝銘鈞; 王德宏; 陸坤泰; 王正一; | 書刊名 | 臺灣醫學會雜誌 |
卷 期 | 96:11 1997.11[民86.11] |
頁 次 | 頁879-883 |
分類號 | 414.83 |
關鍵詞 | 糞便培養; 毒素A; Clostridium difficile; Pseudomembranous colitis; Endoscopy; Stool culture; Toxin a; |
語 文 | 英文(English) |
英文摘要 | This retrospective study was designed to asses the roles of stool culture for clostridium difficile, detection of the presence of toxin A, and endoscopic examination in the diagnosis of clostridium difficile-associated disease (CDAD). From January 1994 through September 1996, there were 213 patients with stool cultures positive for G. difficile in National Taiwan University Hospital. Of these, 126 had CDAD. There were 87 asymptomatic carriers of G. difficile in our study, 12 of whom were positive for toxin A. In addition, seven patients with pseudomembranous colitis (PMC), who were either culture-negative or not tested, were included in the study. The positive predictive values of stool cultures for CDAD and PMC were 59% and 32%, respectively. The positive predictive values of toxin A for CDAD and PMC were 41% and 43%, respectively. Seventy-eight patients (59%) improved with supportive treatment after discontinuing antibiotics. We concluded that stool culture for G. difficile and discontinuation of antibiotics should be the standard approach for patients with suspected CDAD. Endoscopic studies can eliminate some other possibile causes of diarrhea such as inflammatory bowel disease, allow biopsies of suspicious lesions, and reveal the severity of CDAD. Toxin assay results need to be interpreted together with the clinical data. |
本系統中英文摘要資訊取自各篇刊載內容。